| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |